Table 2.
Effect of adjuvant therapy on (recurrence-free) survival.
| Stage 2 − adj Tx | Stage 2 + adj Tx | p | Stage 3 − adj Tx | Stage 3 + adj Tx | p | |
|---|---|---|---|---|---|---|
| Number of patients | 139 | 9 | 38 | 57 | ||
| Recurrence rate | 0,19 | 0,33 | 0,379 | 0,42 | 0,4 | 1,000 |
| Median OS (iqr) | 6,42 (4,25–8,59) | 6,17 (2,08–7,42) | 0,772 | 1,79 (0,60–6,07) | 5,51 (4,06–7,47) | 0,000 |
| Median RFS (iqr) | 5,73 (2.76–8,11) | 5,49 (1.33–7,31) | 0,325 | 1,19 (0,36–5,94) | 5,08 (2,12–7,40) | 0,084 |
| Median age (iqr) | 75,3 (65,4–80,4) | 61,0 (59,3–65,7) | 0,002 | 78,7 (73,9–83,1) | 63,5 (59,8–69,8) | 0,000 |
| Median Charlson index (iqr) | 5 (3–6) | 3 (2–4.5) | 0,038 | 5 (4–6) | 3 (3-4) | 0,000 |
| Cause of death (%) | ||||||
| Alive | 87 (56) | 5 (56) | 8 (21) | 32 (56) | ||
| Cancer | 18 (13) | 3 (33) | 15 (40) | 18 (32) | ||
| Treatment | 3 (2) | 1 (11) | 8 (21) | 0 | ||
| Other | 29 (21) | 0 | 6 (16) | 5 (9) | ||
| Unknown | 11 (8) | 0 | 1 (3) | 2 (4) |
Adj Tx = adjuvant therapy; iqr = interquartile range; OS = overall survival; RFS = recurrence-free survival.